-
Jason
Pirone,
Monica
D’Arcy,
Delisha
Stewart,
W.
Hines,
Melissa
Johnson,
N.
Michael,
Gould,
P.
Yaswen,
D.
Jerry,
S.
Schneider,
M.
Troester
(2012)
Age-Associated Gene Expression in Normal Breast Tissue Mirrors Qualitative Age-at-Incidence Patterns for Breast Cancer
Cancer Epidemiology, Biomarkers & Prevention, 21
-
The ATM–Chk2 and ATR–Chk1 pathways in DNA damage signaling and cancer (Chapter 3)
-
(
YanT
DesaiAB
JacobbergerJW
, et al. CHK1 and CHK2 are differentially involved in mismatch repair–mediated 6-thioguanine-induced cell cycle checkpoint responses. Mol Cancer Ther
2004; 3: 1147–1157.15367709)
YanT
DesaiAB
JacobbergerJW
, et al. CHK1 and CHK2 are differentially involved in mismatch repair–mediated 6-thioguanine-induced cell cycle checkpoint responses. Mol Cancer Ther
2004; 3: 1147–1157.15367709
YanT
DesaiAB
JacobbergerJW
, et al. CHK1 and CHK2 are differentially involved in mismatch repair–mediated 6-thioguanine-induced cell cycle checkpoint responses. Mol Cancer Ther
2004; 3: 1147–1157.15367709,
YanT
DesaiAB
JacobbergerJW
, et al. CHK1 and CHK2 are differentially involved in mismatch repair–mediated 6-thioguanine-induced cell cycle checkpoint responses. Mol Cancer Ther
2004; 3: 1147–1157.15367709
-
B.
Wójcik,
Martha
Spinks,
C.
Stein
(2003)
Effects of Screening Mammography on the Comparative Survival Rates of African American, White, and Hispanic Beneficiaries of a Comprehensive Health Care System
The Breast Journal, 9
-
S.
Holm
(1979)
A Simple Sequentially Rejective Multiple Test Procedure
Scandinavian Journal of Statistics, 6
-
(
WojcikBE
SpinksMK
SteinCR
. Effects of screening mammography on the comparative survival rates of African American, White, and Hispanic beneficiaries of a comprehensive health care system. Breast J
2003; 9: 175–183.12752625)
WojcikBE
SpinksMK
SteinCR
. Effects of screening mammography on the comparative survival rates of African American, White, and Hispanic beneficiaries of a comprehensive health care system. Breast J
2003; 9: 175–183.12752625
WojcikBE
SpinksMK
SteinCR
. Effects of screening mammography on the comparative survival rates of African American, White, and Hispanic beneficiaries of a comprehensive health care system. Breast J
2003; 9: 175–183.12752625,
WojcikBE
SpinksMK
SteinCR
. Effects of screening mammography on the comparative survival rates of African American, White, and Hispanic beneficiaries of a comprehensive health care system. Breast J
2003; 9: 175–183.12752625
-
A.
Menendez-Tuckman,
C.
Raventós-Suárez
(1994)
Re: Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
Journal of the National Cancer Institute, 86 17
-
Marc
Emerson,
Yvonne
Golightly,
X.
Tan,
Allison
Aiello,
K.
Reeder-Hayes,
A.
Olshan,
H.
Earp,
M.
Troester
(2020)
Integrating access to care and tumor patterns by race and age in the Carolina Breast Cancer Study, 2008–2013
Cancer Causes & Control, 31
-
(
BaoPP
CaiH
PengP
, et al. Body mass index and weight change in relation to triple-negative breast cancer survival. Cancer Causes Control
2016; 27: 229–236.26621544)
BaoPP
CaiH
PengP
, et al. Body mass index and weight change in relation to triple-negative breast cancer survival. Cancer Causes Control
2016; 27: 229–236.26621544
BaoPP
CaiH
PengP
, et al. Body mass index and weight change in relation to triple-negative breast cancer survival. Cancer Causes Control
2016; 27: 229–236.26621544,
BaoPP
CaiH
PengP
, et al. Body mass index and weight change in relation to triple-negative breast cancer survival. Cancer Causes Control
2016; 27: 229–236.26621544
-
John
Storey
(2002)
A direct approach to false discovery rates
Journal of the Royal Statistical Society: Series B (Statistical Methodology), 64
-
(
CeccaldiR
RondinelliB
D’AndreaAD
. Repair pathway choices and consequences at the double-strand break. Trends Cell Biol
2016; 26: 52–64.26437586)
CeccaldiR
RondinelliB
D’AndreaAD
. Repair pathway choices and consequences at the double-strand break. Trends Cell Biol
2016; 26: 52–64.26437586
CeccaldiR
RondinelliB
D’AndreaAD
. Repair pathway choices and consequences at the double-strand break. Trends Cell Biol
2016; 26: 52–64.26437586,
CeccaldiR
RondinelliB
D’AndreaAD
. Repair pathway choices and consequences at the double-strand break. Trends Cell Biol
2016; 26: 52–64.26437586
-
(
DanforthDN
. Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors. Breast Cancer Res
2013; 15: 208.23826992)
DanforthDN
. Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors. Breast Cancer Res
2013; 15: 208.23826992
DanforthDN
. Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors. Breast Cancer Res
2013; 15: 208.23826992,
DanforthDN
. Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors. Breast Cancer Res
2013; 15: 208.23826992
-
(
RauscherGH
CampbellRT
WileyEL
, et al. Mediation of racial and ethnic disparities in estrogen/progesterone receptor-negative breast cancer by socioeconomic position and reproductive factors. Am J Epidemiol
2016; 183: 884–893.27076668)
RauscherGH
CampbellRT
WileyEL
, et al. Mediation of racial and ethnic disparities in estrogen/progesterone receptor-negative breast cancer by socioeconomic position and reproductive factors. Am J Epidemiol
2016; 183: 884–893.27076668
RauscherGH
CampbellRT
WileyEL
, et al. Mediation of racial and ethnic disparities in estrogen/progesterone receptor-negative breast cancer by socioeconomic position and reproductive factors. Am J Epidemiol
2016; 183: 884–893.27076668,
RauscherGH
CampbellRT
WileyEL
, et al. Mediation of racial and ethnic disparities in estrogen/progesterone receptor-negative breast cancer by socioeconomic position and reproductive factors. Am J Epidemiol
2016; 183: 884–893.27076668
-
M.
Anurag,
Nindo
Punturi,
J.
Hoog,
M.
Bainbridge,
M.
Ellis,
S.
Haricharan
(2018)
Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers
Clinical Cancer Research, 24
-
Erica
Warner,
R.
Tamimi,
M.
Hughes,
R.
Ottesen,
Y.
Wong,
S.
Edge,
R.
Theriault,
D.
Blayney,
J.
Niland,
E.
Winer,
J.
Weeks,
A.
Partridge
(2015)
Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 20
-
(
AnuragM
HaricharanS
EllisMJ
. CDK4/6 inhibitor biomarker research: are we barking up the wrong tree?
Clin Cancer Res
2020; 26: 3–5.31690650)
AnuragM
HaricharanS
EllisMJ
. CDK4/6 inhibitor biomarker research: are we barking up the wrong tree?
Clin Cancer Res
2020; 26: 3–5.31690650
AnuragM
HaricharanS
EllisMJ
. CDK4/6 inhibitor biomarker research: are we barking up the wrong tree?
Clin Cancer Res
2020; 26: 3–5.31690650,
AnuragM
HaricharanS
EllisMJ
. CDK4/6 inhibitor biomarker research: are we barking up the wrong tree?
Clin Cancer Res
2020; 26: 3–5.31690650
-
(
HolmS
. A simple sequentially rejective multiple test procedure. Scand J Stat
1979; 6: 65–70.)
HolmS
. A simple sequentially rejective multiple test procedure. Scand J Stat
1979; 6: 65–70.
HolmS
. A simple sequentially rejective multiple test procedure. Scand J Stat
1979; 6: 65–70.,
HolmS
. A simple sequentially rejective multiple test procedure. Scand J Stat
1979; 6: 65–70.
-
D.
Jr
(2013)
Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors
Breast Cancer Research, 15
-
Huiyan
Ma,
Yani
Lu,
K.
Malone,
P.
Marchbanks,
D.
Deapen,
R.
Spirtas,
R.
Burkman,
B.
Strom,
Jill
McDonald,
S.
Folger,
M.
Simon,
J.
Sullivan‐Halley,
M.
Press,
L.
Bernstein
(2013)
Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status
BMC Cancer, 13
-
S.
Haricharan,
Nindo
Punturi,
Purba
Singh,
Kimberly
Holloway,
M.
Anurag,
J.
Schmelz,
Cheryl
Schmidt,
Jonathan
Lei,
V.
Suman,
K.
Hunt,
J.
Olson,
J.
Hoog,
Shunqiang
Li,
Shixia
Huang,
D.
Edwards,
Shyam
Kavuri,
M.
Bainbridge,
Cynthia
Ma,
M.
Ellis
(2017)
Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.
Cancer discovery, 7 10
-
T.
Yan,
Anand
Desai,
J.
Jacobberger,
R.
Sramkoski,
Tamalette
Loh,
T.
Kinsella
(2004)
CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.
Molecular cancer therapeutics, 3 9
-
L.
Lovejoy,
Yvonne
Eaglehouse,
M.
Hueman,
Bradley
Mostoller,
C.
Shriver,
R.
Ellsworth
(2019)
Evaluation of Surgical Disparities Between African American and European American Women Treated for Breast Cancer Within an Equal-Access Military Hospital
Annals of Surgical Oncology, 26
-
N.
Costantino,
Benjamin
Freeman,
C.
Shriver,
R.
Ellsworth
(2016)
Outcome Disparities in African American Compared with European American Women with ER+HER2- Tumors Treated within an Equal-Access Health Care System.
Ethnicity & disease, 26 3
-
(
RenY
BlackDM
MittendorfEA
, et al. Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race. PLoS ONE
2014; 9: e110281.)
RenY
BlackDM
MittendorfEA
, et al. Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race. PLoS ONE
2014; 9: e110281.
RenY
BlackDM
MittendorfEA
, et al. Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race. PLoS ONE
2014; 9: e110281.,
RenY
BlackDM
MittendorfEA
, et al. Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race. PLoS ONE
2014; 9: e110281.
-
(
LovejoyLA
EaglehouseYL
HuemanMT
, et al. Evaluation of surgical disparities between African American and European American women treated for breast cancer within an equal-access military hospital. Ann Surg Oncol
2019; 26: 3838–3845.31410609)
LovejoyLA
EaglehouseYL
HuemanMT
, et al. Evaluation of surgical disparities between African American and European American women treated for breast cancer within an equal-access military hospital. Ann Surg Oncol
2019; 26: 3838–3845.31410609
LovejoyLA
EaglehouseYL
HuemanMT
, et al. Evaluation of surgical disparities between African American and European American women treated for breast cancer within an equal-access military hospital. Ann Surg Oncol
2019; 26: 3838–3845.31410609,
LovejoyLA
EaglehouseYL
HuemanMT
, et al. Evaluation of surgical disparities between African American and European American women treated for breast cancer within an equal-access military hospital. Ann Surg Oncol
2019; 26: 3838–3845.31410609
-
Jason
Pitt,
Markus
Riester,
Yonglan
Zheng,
T.
Yoshimatsu,
A.
Sanni,
O.
Oluwasola,
Artur
Veloso,
E.
Labrot,
Shengfeng
Wang,
A.
Odetunde,
A.
Ademola,
B.
Okedere,
Scott
Mahan,
R.
Leary,
Maura
Macomber,
M.
Ajani,
Ryan
Johnson,
Dominic
Fitzgerald,
A.
Grundstad,
Jigyasa
Tuteja,
G.
Khramtsova,
Jing
Zhang,
Elisabeth
Sveen,
B.
Hwang,
W.
Clayton,
C.
Nkwodimmah,
Bisola
Famooto,
E.
Obasi,
Victor
Aderoju,
M.
Oludara,
F.
Omodele,
Odunayo
Akinyele,
A.
Adeoye,
T.
Ogundiran,
C.
Babalola,
K.
MacIsaac,
A.
Popoola,
Michael
Morrissey,
Lin
Chen,
Jiebiao
Wang,
C.
Olopade,
A.
Falusi,
W.
Winckler,
K.
Haase,
P.
Loo,
J.
Obafunwa,
D.
Papoutsakis,
O.
Ojengbede,
B.
Weber,
N.
Ibrahim,
Kevin
White,
D.
Huo,
O.
Olopade,
J.
Barretina
(2018)
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Nature Communications, 9
-
J.
Sparano,
Molin
Wang,
Fengmin
Zhao,
V.
Stearns,
S.
Martino,
J.
Ligibel,
E.
Perez,
T.
Saphner,
A.
Wolff,
G.
Sledge,
W.
Wood,
N.
Davidson
(2012)
Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
Journal of the National Cancer Institute, 104 5
-
J.
Smith,
L.
Tho,
N.
Xu,
D.
Gillespie
(2010)
The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
Advances in cancer research, 108
-
(
CostantinoNS
FreemanB
ShriverCD
, et al. Outcome disparities in African American compared with European American Women with ER+HER2- tumors treated within an equal-access health care system. Ethn Dis
2016; 26: 407–416.27440982)
CostantinoNS
FreemanB
ShriverCD
, et al. Outcome disparities in African American compared with European American Women with ER+HER2- tumors treated within an equal-access health care system. Ethn Dis
2016; 26: 407–416.27440982
CostantinoNS
FreemanB
ShriverCD
, et al. Outcome disparities in African American compared with European American Women with ER+HER2- tumors treated within an equal-access health care system. Ethn Dis
2016; 26: 407–416.27440982,
CostantinoNS
FreemanB
ShriverCD
, et al. Outcome disparities in African American compared with European American Women with ER+HER2- tumors treated within an equal-access health care system. Ethn Dis
2016; 26: 407–416.27440982
-
(
SparanoJA
WangM
ZhaoF
, et al. Race and hormone receptor–positive breast cancer outcomes in a randomized chemotherapy trial. J Natl Cancer Inst
2012; 104: 406–414.22250182)
SparanoJA
WangM
ZhaoF
, et al. Race and hormone receptor–positive breast cancer outcomes in a randomized chemotherapy trial. J Natl Cancer Inst
2012; 104: 406–414.22250182
SparanoJA
WangM
ZhaoF
, et al. Race and hormone receptor–positive breast cancer outcomes in a randomized chemotherapy trial. J Natl Cancer Inst
2012; 104: 406–414.22250182,
SparanoJA
WangM
ZhaoF
, et al. Race and hormone receptor–positive breast cancer outcomes in a randomized chemotherapy trial. J Natl Cancer Inst
2012; 104: 406–414.22250182
-
(
O’LearyB
FinnRS
TurnerNC
. Treating cancer with selective CDK4/6 inhibitors. Nat Rev Clin Oncol
2016; 13: 417–430.27030077)
O’LearyB
FinnRS
TurnerNC
. Treating cancer with selective CDK4/6 inhibitors. Nat Rev Clin Oncol
2016; 13: 417–430.27030077
O’LearyB
FinnRS
TurnerNC
. Treating cancer with selective CDK4/6 inhibitors. Nat Rev Clin Oncol
2016; 13: 417–430.27030077,
O’LearyB
FinnRS
TurnerNC
. Treating cancer with selective CDK4/6 inhibitors. Nat Rev Clin Oncol
2016; 13: 417–430.27030077
-
G.
Rauscher,
Abigail
Silva,
Heather
Pauls,
J.
Frasor,
M.
Bonini,
K.
Hoskins
(2017)
Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities
Breast Cancer Research and Treatment, 163
-
(
PironeJR
D’ArcyM
StewartDA
, et al. Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer. Cancer Epidemiol Biomarkers Prev
2012; 21: 1735–1744.22859400)
PironeJR
D’ArcyM
StewartDA
, et al. Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer. Cancer Epidemiol Biomarkers Prev
2012; 21: 1735–1744.22859400
PironeJR
D’ArcyM
StewartDA
, et al. Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer. Cancer Epidemiol Biomarkers Prev
2012; 21: 1735–1744.22859400,
PironeJR
D’ArcyM
StewartDA
, et al. Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer. Cancer Epidemiol Biomarkers Prev
2012; 21: 1735–1744.22859400
-
M.
Anurag,
S.
Haricharan,
M.
Ellis
(2019)
CDK4/6 Inhibitor Biomarker Research: Are We Barking Up the Wrong Tree?
Clinical Cancer Research, 26
-
G.
Rauscher,
R.
Campbell,
E.
Wiley,
K.
Hoskins,
M.
Stolley,
R.
Warnecke
(2016)
Mediation of Racial and Ethnic Disparities in Estrogen/Progesterone Receptor-Negative Breast Cancer by Socioeconomic Position and Reproductive Factors.
American journal of epidemiology, 183 10
-
R.
Finn,
J.
Dering,
D.
Conklin,
O.
Kalous,
David
Cohen,
Amrita
Desai,
C.
Ginther,
M.
Atefi,
I.
Chen,
C.
Fowst,
G.
Los,
D.
Slamon
(2009)
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
Breast Cancer Research : BCR, 11
-
C.
Perou,
T.
Sørlie,
M.
Eisen,
M.
Rijn,
S.
Jeffrey,
Christian
Rees,
J.
Pollack,
D.
Ross,
H.
Johnsen,
L.
Akslen,
Ø.
Fluge,
Alexander
Pergamenschikov,
Cheryl
Williams,
Shirley
Zhu,
P.
Lønning,
A.
Børresen-Dale,
P.
Brown,
D.
Botstein
(2000)
Molecular portraits of human breast tumours
Nature, 406
-
(
Menendez-TuckmanAT
Raventos-SuarezC
. Re: tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst
1994; 86: 1352–1353.8064896)
Menendez-TuckmanAT
Raventos-SuarezC
. Re: tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst
1994; 86: 1352–1353.8064896
Menendez-TuckmanAT
Raventos-SuarezC
. Re: tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst
1994; 86: 1352–1353.8064896,
Menendez-TuckmanAT
Raventos-SuarezC
. Re: tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst
1994; 86: 1352–1353.8064896
-
D.
Ma,
Siliang
Chen,
Jin-Xiao
Ren,
Yuchen
Pei,
Congwei
Jiang,
Shen
Zhao,
Yi
Xiao,
Xiao-En
Xu,
Guangyu
Liu,
Xin
Hu,
Xiaozhen
Liang,
Keda
Yu,
Da-Qiang
Li,
Yizhou
Jiang,
Z.
Shao
(2020)
Molecular features and functional implications of germline variants in triple-negative breast cancer.
Journal of the National Cancer Institute
-
(
HankerAB
SudhanDR
ArteagaCL
. Overcoming endocrine resistance in breast cancer. Cancer Cell
2020; 37: 496–513.32289273)
HankerAB
SudhanDR
ArteagaCL
. Overcoming endocrine resistance in breast cancer. Cancer Cell
2020; 37: 496–513.32289273
HankerAB
SudhanDR
ArteagaCL
. Overcoming endocrine resistance in breast cancer. Cancer Cell
2020; 37: 496–513.32289273,
HankerAB
SudhanDR
ArteagaCL
. Overcoming endocrine resistance in breast cancer. Cancer Cell
2020; 37: 496–513.32289273
-
(
MaH
LuY
MaloneKE
, et al. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status. BMC Cancer
2013; 13: 225.23642215)
MaH
LuY
MaloneKE
, et al. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status. BMC Cancer
2013; 13: 225.23642215
MaH
LuY
MaloneKE
, et al. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status. BMC Cancer
2013; 13: 225.23642215,
MaH
LuY
MaloneKE
, et al. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status. BMC Cancer
2013; 13: 225.23642215
-
(
JacksonSP
BartekJ
. The DNA-damage response in human biology and disease. Nature
2009; 461: 1071–1078.19847258)
JacksonSP
BartekJ
. The DNA-damage response in human biology and disease. Nature
2009; 461: 1071–1078.19847258
JacksonSP
BartekJ
. The DNA-damage response in human biology and disease. Nature
2009; 461: 1071–1078.19847258,
JacksonSP
BartekJ
. The DNA-damage response in human biology and disease. Nature
2009; 461: 1071–1078.19847258
-
(2021)
Differences in Tumor Biology, Health Care Access, and Social Support May Contribute to Worse Outcomes for Black Patients with Breast Cancer.
The oncologist
-
Patricia
Casbas-Hernández,
Xuezheng
Sun,
Erick
Román-Pérez,
Monica
D’Arcy,
Rupninder
Sandhu,
A.
Hishida,
K.
McNaughton,
Xiaohong
Yang,
L.
Makowski,
M.
Sherman,
J.
Figueroa,
M.
Troester
(2014)
Tumor Intrinsic Subtype Is Reflected in Cancer-Adjacent Tissue
Cancer Epidemiology, Biomarkers & Prevention, 24
-
E.
Cerami,
Jianjiong
Gao,
U.
Dogrusoz,
Benjamin
Gross,
S.
Sumer,
B.
Aksoy,
A.
Jacobsen,
Caitlin
Byrne,
M.
Heuer,
E.
Larsson,
Yevgeniy
Antipin,
B.
Reva,
A.
Goldberg,
C.
Sander,
N.
Schultz
(2012)
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Cancer discovery, 2 5
-
(
D’ArcyM
FlemingJ
RobinsonWR
, et al. Race-associated biological differences among Luminal A breast tumors. Breast Cancer Res Treat
2015; 152: 437–448.26109344)
D’ArcyM
FlemingJ
RobinsonWR
, et al. Race-associated biological differences among Luminal A breast tumors. Breast Cancer Res Treat
2015; 152: 437–448.26109344
D’ArcyM
FlemingJ
RobinsonWR
, et al. Race-associated biological differences among Luminal A breast tumors. Breast Cancer Res Treat
2015; 152: 437–448.26109344,
D’ArcyM
FlemingJ
RobinsonWR
, et al. Race-associated biological differences among Luminal A breast tumors. Breast Cancer Res Treat
2015; 152: 437–448.26109344
-
A.
Hanker,
D.
Sudhan,
C.
Arteaga
(2020)
Overcoming Endocrine Resistance in Breast Cancer.
Cancer cell, 37 4
-
(
LeeKWC
LordS
FinnRS
, et al. The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis. Breast Cancer Res Treat
2019; 174: 271–278.30465154)
LeeKWC
LordS
FinnRS
, et al. The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis. Breast Cancer Res Treat
2019; 174: 271–278.30465154
LeeKWC
LordS
FinnRS
, et al. The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis. Breast Cancer Res Treat
2019; 174: 271–278.30465154,
LeeKWC
LordS
FinnRS
, et al. The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis. Breast Cancer Res Treat
2019; 174: 271–278.30465154
-
C.
DeSantis,
Jiemin
Ma,
M.
Gaudet,
L.
Newman,
K.
Miller,
Ann
Sauer,
A.
Jemal,
R.
Siegel
(2019)
Breast cancer statistics, 2019
CA: A Cancer Journal for Clinicians, 69
-
K.
Lee,
S.
Lord,
R.
Finn,
E.
Lim,
A.
Martin,
S.
Loi,
J.
Lynch,
M.
Friedlander,
C.
Lee
(2018)
The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis
Breast Cancer Research and Treatment, 174
-
(
TorioCM
KlassenAC
CurrieroFC
, et al. The modifying effect of social class on the relationship between body mass index and breast cancer incidence. Am J Public Health
2010; 100: 146–151.19150917)
TorioCM
KlassenAC
CurrieroFC
, et al. The modifying effect of social class on the relationship between body mass index and breast cancer incidence. Am J Public Health
2010; 100: 146–151.19150917
TorioCM
KlassenAC
CurrieroFC
, et al. The modifying effect of social class on the relationship between body mass index and breast cancer incidence. Am J Public Health
2010; 100: 146–151.19150917,
TorioCM
KlassenAC
CurrieroFC
, et al. The modifying effect of social class on the relationship between body mass index and breast cancer incidence. Am J Public Health
2010; 100: 146–151.19150917
-
(
FurbergH
MillikanR
DresslerL
, et al. Tumor characteristics in African American and white women. Breast Cancer Res Treat
2001; 68: 33–43.11678307)
FurbergH
MillikanR
DresslerL
, et al. Tumor characteristics in African American and white women. Breast Cancer Res Treat
2001; 68: 33–43.11678307
FurbergH
MillikanR
DresslerL
, et al. Tumor characteristics in African American and white women. Breast Cancer Res Treat
2001; 68: 33–43.11678307,
FurbergH
MillikanR
DresslerL
, et al. Tumor characteristics in African American and white women. Breast Cancer Res Treat
2001; 68: 33–43.11678307
-
(
WatlingtonAT
ByersT
MouchawarJ
, et al. Does having insurance affect differences in clinical presentation between Hispanic and non-Hispanic white women with breast cancer?
Cancer
2007; 109: 2093–2099.17420982)
WatlingtonAT
ByersT
MouchawarJ
, et al. Does having insurance affect differences in clinical presentation between Hispanic and non-Hispanic white women with breast cancer?
Cancer
2007; 109: 2093–2099.17420982
WatlingtonAT
ByersT
MouchawarJ
, et al. Does having insurance affect differences in clinical presentation between Hispanic and non-Hispanic white women with breast cancer?
Cancer
2007; 109: 2093–2099.17420982,
WatlingtonAT
ByersT
MouchawarJ
, et al. Does having insurance affect differences in clinical presentation between Hispanic and non-Hispanic white women with breast cancer?
Cancer
2007; 109: 2093–2099.17420982
-
(2010)
The modifying effect of social class on the relationship between body mass index and breast Therapeutic Advances in Medical Oncology 14 12 journals.sagepub.com/home/tam cancer incidence
-
(
TroesterMA
SunX
AllottEH
, et al. Racial differences in PAM50 subtypes in the Carolina Breast Cancer Study. J Natl Cancer Inst
2018; 110: 176–182.)
TroesterMA
SunX
AllottEH
, et al. Racial differences in PAM50 subtypes in the Carolina Breast Cancer Study. J Natl Cancer Inst
2018; 110: 176–182.
TroesterMA
SunX
AllottEH
, et al. Racial differences in PAM50 subtypes in the Carolina Breast Cancer Study. J Natl Cancer Inst
2018; 110: 176–182.,
TroesterMA
SunX
AllottEH
, et al. Racial differences in PAM50 subtypes in the Carolina Breast Cancer Study. J Natl Cancer Inst
2018; 110: 176–182.
-
(
JemalA
RobbinsAS
LinCC
, et al. Factors that contributed to Black-White disparities in survival among nonelderly women with breast cancer between 2004 and 2013. J Clin Oncol
2018; 36: 14–24.29035645)
JemalA
RobbinsAS
LinCC
, et al. Factors that contributed to Black-White disparities in survival among nonelderly women with breast cancer between 2004 and 2013. J Clin Oncol
2018; 36: 14–24.29035645
JemalA
RobbinsAS
LinCC
, et al. Factors that contributed to Black-White disparities in survival among nonelderly women with breast cancer between 2004 and 2013. J Clin Oncol
2018; 36: 14–24.29035645,
JemalA
RobbinsAS
LinCC
, et al. Factors that contributed to Black-White disparities in survival among nonelderly women with breast cancer between 2004 and 2013. J Clin Oncol
2018; 36: 14–24.29035645
-
A.
Watlington,
T.
Byers,
J.
Mouchawar,
A.
Sauaia,
J.
Ellis
(2007)
Does having insurance affect differences in clinical presentation between Hispanic and non‐Hispanic white women with breast cancer?
Cancer, 109
-
(
CeramiE
GaoJ
DogrusozU
, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov
2012; 2: 401–404.22588877)
CeramiE
GaoJ
DogrusozU
, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov
2012; 2: 401–404.22588877
CeramiE
GaoJ
DogrusozU
, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov
2012; 2: 401–404.22588877,
CeramiE
GaoJ
DogrusozU
, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov
2012; 2: 401–404.22588877
-
(
EmersonMA
GolightlyYM
TanX
, et al. Integrating access to care and tumor patterns by race and age in the Carolina Breast Cancer Study, 2008-2013. Cancer Causes Control
2020; 31: 221–230.31950321)
EmersonMA
GolightlyYM
TanX
, et al. Integrating access to care and tumor patterns by race and age in the Carolina Breast Cancer Study, 2008-2013. Cancer Causes Control
2020; 31: 221–230.31950321
EmersonMA
GolightlyYM
TanX
, et al. Integrating access to care and tumor patterns by race and age in the Carolina Breast Cancer Study, 2008-2013. Cancer Causes Control
2020; 31: 221–230.31950321,
EmersonMA
GolightlyYM
TanX
, et al. Integrating access to care and tumor patterns by race and age in the Carolina Breast Cancer Study, 2008-2013. Cancer Causes Control
2020; 31: 221–230.31950321
-
I.
Menashe,
W.
Anderson,
I.
Jatoi,
P.
Rosenberg
(2009)
Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis.
Journal of the National Cancer Institute, 101 14
-
(
DuellEJ
MillikanRC
PittmanGS
, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev
2001; 10: 217–222.11303590)
DuellEJ
MillikanRC
PittmanGS
, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev
2001; 10: 217–222.11303590
DuellEJ
MillikanRC
PittmanGS
, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev
2001; 10: 217–222.11303590,
DuellEJ
MillikanRC
PittmanGS
, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev
2001; 10: 217–222.11303590
-
Yu
Ren,
D.
Black,
E.
Mittendorf,
Peijun
Liu,
Xu
Li,
Xianglin
Du,
Jianjun
He,
Jin
Yang,
K.
Hunt,
M.
Yi
(2014)
Crossover Effects of Estrogen Receptor Status on Breast Cancer-Specific Hazard Rates by Age and Race
PLoS ONE, 9
-
(
GaoR
PriceDK
SissungT
, et al. Ethnic disparities in Americans of European descent versus Americans of African descent related to Polymorphic ERCC1, ERCC2, XRCC1 and PARP1. Mol Cancer Ther
2008; 7: 1246–1250.18483312)
GaoR
PriceDK
SissungT
, et al. Ethnic disparities in Americans of European descent versus Americans of African descent related to Polymorphic ERCC1, ERCC2, XRCC1 and PARP1. Mol Cancer Ther
2008; 7: 1246–1250.18483312
GaoR
PriceDK
SissungT
, et al. Ethnic disparities in Americans of European descent versus Americans of African descent related to Polymorphic ERCC1, ERCC2, XRCC1 and PARP1. Mol Cancer Ther
2008; 7: 1246–1250.18483312,
GaoR
PriceDK
SissungT
, et al. Ethnic disparities in Americans of European descent versus Americans of African descent related to Polymorphic ERCC1, ERCC2, XRCC1 and PARP1. Mol Cancer Ther
2008; 7: 1246–1250.18483312
-
M.
Troester,
Xuezheng
Sun,
E.
Allott,
J.
Geradts,
Stephanie
Cohen,
C.
Tse,
Erin
Kirk,
Leigh
Thorne,
M.
Mathews,
Yan
Li,
Zhiyuan
Hu,
Whitney
Robinson,
K.
Hoadley,
O.
Olopade,
K.
Reeder-Hayes,
H.
Earp,
A.
Olshan,
L.
Carey,
C.
Perou
(2018)
Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study
JNCI: Journal of the National Cancer Institute, 110
-
(
SmithJ
Mun ThoL
XuN
, et al. The ATM–Chk2 and ATR–Chk1 pathways in DNA damage signaling and cancer (Chapter 3). In:
Vande WoudeGF
KleinG
(eds) Advances in cancer research, vol. 108. Cambridge, MA: Academic Press, 2010, pp. 73–112.)
SmithJ
Mun ThoL
XuN
, et al. The ATM–Chk2 and ATR–Chk1 pathways in DNA damage signaling and cancer (Chapter 3). In:
Vande WoudeGF
KleinG
(eds) Advances in cancer research, vol. 108. Cambridge, MA: Academic Press, 2010, pp. 73–112.
SmithJ
Mun ThoL
XuN
, et al. The ATM–Chk2 and ATR–Chk1 pathways in DNA damage signaling and cancer (Chapter 3). In:
Vande WoudeGF
KleinG
(eds) Advances in cancer research, vol. 108. Cambridge, MA: Academic Press, 2010, pp. 73–112.,
SmithJ
Mun ThoL
XuN
, et al. The ATM–Chk2 and ATR–Chk1 pathways in DNA damage signaling and cancer (Chapter 3). In:
Vande WoudeGF
KleinG
(eds) Advances in cancer research, vol. 108. Cambridge, MA: Academic Press, 2010, pp. 73–112.
-
A.
Jemal,
A.
Robbins,
C.
Lin,
W.
Flanders,
C.
DeSantis,
E.
Ward,
R.
Freedman
(2018)
Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36 1
-
(
StoreyJD
. A direct approach to false discovery rates. J R Stat Soc Ser B Stat Methodol
2002; 64: 479–498.)
StoreyJD
. A direct approach to false discovery rates. J R Stat Soc Ser B Stat Methodol
2002; 64: 479–498.
StoreyJD
. A direct approach to false discovery rates. J R Stat Soc Ser B Stat Methodol
2002; 64: 479–498.,
StoreyJD
. A direct approach to false discovery rates. J R Stat Soc Ser B Stat Methodol
2002; 64: 479–498.
-
Raphael
Ceccaldi,
B.
Rondinelli,
A.
D’Andrea
(2016)
Repair Pathway Choices and Consequences at the Double-Strand Break.
Trends in cell biology, 26 1
-
(
PerouCM
SørlieT
EisenMB
, et al. Molecular portraits of human breast tumours. Nature
2000; 406: 747–752.10963602)
PerouCM
SørlieT
EisenMB
, et al. Molecular portraits of human breast tumours. Nature
2000; 406: 747–752.10963602
PerouCM
SørlieT
EisenMB
, et al. Molecular portraits of human breast tumours. Nature
2000; 406: 747–752.10963602,
PerouCM
SørlieT
EisenMB
, et al. Molecular portraits of human breast tumours. Nature
2000; 406: 747–752.10963602
-
(
Comparison of breast cancer molecular features and survival by African and European Ancestry in The Cancer Genome Atlas| Breast Cancer| JAMA Oncology| JAMA Network, https://jamanetwork.com/journals/jamaoncology/fullarticle/2624532 (accessed 20 October 2020).)
Comparison of breast cancer molecular features and survival by African and European Ancestry in The Cancer Genome Atlas| Breast Cancer| JAMA Oncology| JAMA Network, https://jamanetwork.com/journals/jamaoncology/fullarticle/2624532 (accessed 20 October 2020).
Comparison of breast cancer molecular features and survival by African and European Ancestry in The Cancer Genome Atlas| Breast Cancer| JAMA Oncology| JAMA Network, https://jamanetwork.com/journals/jamaoncology/fullarticle/2624532 (accessed 20 October 2020).,
Comparison of breast cancer molecular features and survival by African and European Ancestry in The Cancer Genome Atlas| Breast Cancer| JAMA Oncology| JAMA Network, https://jamanetwork.com/journals/jamaoncology/fullarticle/2624532 (accessed 20 October 2020).
-
D.
Huo,
Hai
Hu,
S.
Rhie,
E.
Gamazon,
A.
Cherniack,
Jianfang
Liu,
T.
Yoshimatsu,
Jason
Pitt,
K.
Hoadley,
M.
Troester,
Y.
Ru,
T.
Lichtenberg,
Lori
Sturtz,
C.
Shelley,
C.
Benz,
G.
Mills,
P.
Laird,
C.
Shriver,
C.
Perou,
O.
Olopade
(2017)
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas
JAMA Oncology, 3
-
(
KeyomarsiK
PardeeAB
. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA
1993; 90: 1112–1116.8430082)
KeyomarsiK
PardeeAB
. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA
1993; 90: 1112–1116.8430082
KeyomarsiK
PardeeAB
. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA
1993; 90: 1112–1116.8430082,
KeyomarsiK
PardeeAB
. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA
1993; 90: 1112–1116.8430082
-
(
DeSantisCE
MaJ
GaudetMM
, et al. Breast cancer statistics, 2019. CA Cancer J Clin
2019; 69: 438–451.31577379)
DeSantisCE
MaJ
GaudetMM
, et al. Breast cancer statistics, 2019. CA Cancer J Clin
2019; 69: 438–451.31577379
DeSantisCE
MaJ
GaudetMM
, et al. Breast cancer statistics, 2019. CA Cancer J Clin
2019; 69: 438–451.31577379,
DeSantisCE
MaJ
GaudetMM
, et al. Breast cancer statistics, 2019. CA Cancer J Clin
2019; 69: 438–451.31577379
-
(
HaddadSA
LunettaKL
Ruiz-NarváezEA
, et al. Hormone-related pathways and risk of breast cancer subtypes in African American women. Breast Cancer Res Treat
2015; 154: 145–154.26458823)
HaddadSA
LunettaKL
Ruiz-NarváezEA
, et al. Hormone-related pathways and risk of breast cancer subtypes in African American women. Breast Cancer Res Treat
2015; 154: 145–154.26458823
HaddadSA
LunettaKL
Ruiz-NarváezEA
, et al. Hormone-related pathways and risk of breast cancer subtypes in African American women. Breast Cancer Res Treat
2015; 154: 145–154.26458823,
HaddadSA
LunettaKL
Ruiz-NarváezEA
, et al. Hormone-related pathways and risk of breast cancer subtypes in African American women. Breast Cancer Res Treat
2015; 154: 145–154.26458823
-
(
MaD
ChenSY
RenJX
, et al. Molecular features and functional implications of germline variants in triple-negative breast cancer. J Natl Cancer Inst
2021; 113: 884–892.33151324)
MaD
ChenSY
RenJX
, et al. Molecular features and functional implications of germline variants in triple-negative breast cancer. J Natl Cancer Inst
2021; 113: 884–892.33151324
MaD
ChenSY
RenJX
, et al. Molecular features and functional implications of germline variants in triple-negative breast cancer. J Natl Cancer Inst
2021; 113: 884–892.33151324,
MaD
ChenSY
RenJX
, et al. Molecular features and functional implications of germline variants in triple-negative breast cancer. J Natl Cancer Inst
2021; 113: 884–892.33151324
-
Visit SAGE journals online journals.sagepub.com/ home/tam
-
(
HaricharanS
PunturiN
SinghP
, et al. Loss of MutL disrupts CHK2-dependent cell-cycle control through CDK4/6 to promote intrinsic endocrine therapy resistance in primary breast cancer. Cancer Discov
2017; 7: 1168–1183.28801307)
HaricharanS
PunturiN
SinghP
, et al. Loss of MutL disrupts CHK2-dependent cell-cycle control through CDK4/6 to promote intrinsic endocrine therapy resistance in primary breast cancer. Cancer Discov
2017; 7: 1168–1183.28801307
HaricharanS
PunturiN
SinghP
, et al. Loss of MutL disrupts CHK2-dependent cell-cycle control through CDK4/6 to promote intrinsic endocrine therapy resistance in primary breast cancer. Cancer Discov
2017; 7: 1168–1183.28801307,
HaricharanS
PunturiN
SinghP
, et al. Loss of MutL disrupts CHK2-dependent cell-cycle control through CDK4/6 to promote intrinsic endocrine therapy resistance in primary breast cancer. Cancer Discov
2017; 7: 1168–1183.28801307
-
(
Casbas-HernandezP
SunX
Roman-PerezE
, et al. Tumor intrinsic subtype is reflected in cancer-adjacent tissue. Cancer Epidemiol Biomarkers Prev
2015; 24: 406–414.25465802)
Casbas-HernandezP
SunX
Roman-PerezE
, et al. Tumor intrinsic subtype is reflected in cancer-adjacent tissue. Cancer Epidemiol Biomarkers Prev
2015; 24: 406–414.25465802
Casbas-HernandezP
SunX
Roman-PerezE
, et al. Tumor intrinsic subtype is reflected in cancer-adjacent tissue. Cancer Epidemiol Biomarkers Prev
2015; 24: 406–414.25465802,
Casbas-HernandezP
SunX
Roman-PerezE
, et al. Tumor intrinsic subtype is reflected in cancer-adjacent tissue. Cancer Epidemiol Biomarkers Prev
2015; 24: 406–414.25465802
-
Rui
Gao,
D.
Price,
T.
Sissung,
E.
Reed,
W.
Figg
(2008)
Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1
Molecular Cancer Therapeutics, 7
-
(
WarnerET
TamimiRM
HughesME
, et al. Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol
2015; 33: 2254–2261.25964252)
WarnerET
TamimiRM
HughesME
, et al. Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol
2015; 33: 2254–2261.25964252
WarnerET
TamimiRM
HughesME
, et al. Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol
2015; 33: 2254–2261.25964252,
WarnerET
TamimiRM
HughesME
, et al. Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol
2015; 33: 2254–2261.25964252
-
(
DasikaGK
LinSCJ
ZhaoS
, et al. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene
1999; 18: 7883–7899.10630641)
DasikaGK
LinSCJ
ZhaoS
, et al. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene
1999; 18: 7883–7899.10630641
DasikaGK
LinSCJ
ZhaoS
, et al. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene
1999; 18: 7883–7899.10630641,
DasikaGK
LinSCJ
ZhaoS
, et al. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene
1999; 18: 7883–7899.10630641
-
Gopal
Dasika,
Suh-Chin
Lin,
Song
Zhao,
P.
Sung,
A.
Tomkinson,
E.
Lee
(1999)
DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis
Oncogene, 18
-
Monica
D’Arcy,
Jodie
Fleming,
W.
Robinson,
Erin
Kirk,
C.
Perou,
M.
Troester
(2015)
Race-associated biological differences among Luminal A breast tumors
Breast Cancer Research and Treatment, 152
-
D.
Bell,
E.
Duell,
Allison
Eaton,
R.
Lunn,
R.
Millikan,
H.
Mohrenweiser,
B.
Newman,
G.
Pittman,
C.
Tse,
Scott
Winkel
(2001)
Polymorphisms in the DNA repair gene XRCC1 and breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 10 3
-
(
FinnRS
DeringJ
ConklinD
, et al. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res
2009; 11: R77.19874578)
FinnRS
DeringJ
ConklinD
, et al. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res
2009; 11: R77.19874578
FinnRS
DeringJ
ConklinD
, et al. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res
2009; 11: R77.19874578,
FinnRS
DeringJ
ConklinD
, et al. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res
2009; 11: R77.19874578
-
S.
Jackson,
J.
Bartek
(2009)
The DNA-damage response in human biology and disease
Nature, 461
-
H.
Furberg,
R.
Millikan,
L.
Dressler,
B.
Newman,
J.
Geradts
(2001)
Tumor characteristics in African American and white women
Breast Cancer Research and Treatment, 68
-
K.
Keyomarsi,
A.
Pardee
(1993)
Redundant cyclin overexpression and gene amplification in breast cancer cells.
Proceedings of the National Academy of Sciences of the United States of America, 90
-
S.
Haddad,
K.
Lunetta,
E.
Ruiz-Narváez,
J.
Bensen,
C.
Hong,
Lara
Sucheston-Campbell,
S.
Yao,
E.
Bandera,
L.
Rosenberg,
C.
Haiman,
M.
Troester,
C.
Ambrosone,
J.
Palmer
(2015)
Hormone-related pathways and risk of breast cancer subtypes in African American women
Breast Cancer Research and Treatment, 154
-
(
PittJJ
RiesterM
ZhengY
, et al. Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. Nat Commun
2018; 9: 4181.30327465)
PittJJ
RiesterM
ZhengY
, et al. Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. Nat Commun
2018; 9: 4181.30327465
PittJJ
RiesterM
ZhengY
, et al. Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. Nat Commun
2018; 9: 4181.30327465,
PittJJ
RiesterM
ZhengY
, et al. Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. Nat Commun
2018; 9: 4181.30327465
-
(
MenasheI
AndersonWF
JatoiI
, et al. Underlying causes of the Black–White racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst
2009; 101: 993–1000.19584327)
MenasheI
AndersonWF
JatoiI
, et al. Underlying causes of the Black–White racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst
2009; 101: 993–1000.19584327
MenasheI
AndersonWF
JatoiI
, et al. Underlying causes of the Black–White racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst
2009; 101: 993–1000.19584327,
MenasheI
AndersonWF
JatoiI
, et al. Underlying causes of the Black–White racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst
2009; 101: 993–1000.19584327
-
S.
Haricharan,
M.
Bainbridge,
P.
Scheet,
P.
Brown
(2014)
Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data
Breast Cancer Research and Treatment, 146
-
P.
Bao,
H.
Cai,
P.
Peng,
K.
Gu,
Yinghao
Su,
X.
Shu,
Ying
Zheng
(2016)
Body mass index and weight change in relation to triple-negative breast cancer survival
Cancer Causes & Control, 27
-
The modifying effect of social class on the relationship between body mass index and breast cancer incidence
-
B.
O’Leary,
R.
Finn,
N.
Turner
(2016)
Treating cancer with selective CDK4/6 inhibitors
Nature Reviews Clinical Oncology, 13